Conferences - Results from #6740

ESOU 2019: An Update in Prostate Cancer Prevention January 21, 2019

ESOU 2019: Treating Primary Metastatic Disease, a Case for Surgery Plus or Minus Radiotherapy January 21, 2019

ESOU 2019: Symptomatic Metastatic Castration-sensitive Hormone-naïve Prostate Cancer: Evidence from CHAARTED, LATITUDE, and STAMPEDE January 21, 2019

ESOU 2019: Oligo-Metastatic Disease Today - Diagnostic and Treatment January 21, 2019

ESOU 2019: Debate: T2 Renal Tumors Best Surgical Treatment: Radical Nephrectomy January 21, 2019

ESOU 2019: Debate: T2 Renal Tumors Best Surgical Treatment: Partial Nephrectomy January 21, 2019

ESOU 2019: Risk Stratification for Active Surveillance January 21, 2019

ESOU 2019: Surgery: High Quality Local Treatment in High Risk Localized Prostate Cancer January 21, 2019

ESOU 2019: Radiotherapy: High Quality Local Treatment in High Risk Localized Prostate Cancer January 21, 2019

ESOU 2019: Best of Uro-Oncology 2018 – Urothelial Cancer January 20, 2019

ESOU 2019: Revolution in the First Line Treatment for Metastatic Renal Cell Carcinoma: Where Do We Stand? January 20, 2019

ESOU 2019: Best of Uro-Oncology 2018 - Prostate Cancer January 20, 2019

ESOU 2019: Adjuvant Therapy after Nephrectomy for High Risk Renal Cell Carcinoma: The Oncologist's Perspective January 20, 2019

ESOU 2019: Cytoreductive Nephrectomy: What are the Current Recommendations? January 20, 2019

ESOU 2019: Adjuvant Therapy after Nephrectomy for High Risk Renal Cell Carcinoma: The Urologist's Perspective January 20, 2019

ESOU 2019: Best of Uro-Oncology 2018: Renal Cancer January 20, 2019

ESOU 2019: Minimally Invasive Inguinal Lymphadenectomy January 20, 2019

ESOU 2019: Molecular Markers for Staging and Monitoring Testis Cancer January 20, 2019

ESOU 2019: Best of Uro-Oncology 2018: Penile and Testis Cancer January 20, 2019

ESOU 2019: The Role of RPLND in Tumor Marker Negative Stage IIA-B: CON January 20, 2019

Page 338 of 594